Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Concordia International Becomes ADVANZ PHARMA | Contract Pharma
Breaking News

Concordia International Becomes ADVANZ PHARMA

The resolution was voted for by shareholders, and approximately 99.9 per cent of the votes cast were in favor of the change

Concordia International Corp. has changed its name to ADVANZ PHARMA Corp. The resolution was voted for by shareholders, and approximately 99.9 per cent of the votes cast were in favor of the change.

It is expected that the limited voting shares of the Company will begin trading under the new name, and that the Company’s stock symbol will change from CXR to ADVZ, on or about December 3, 2018. 

“This is an exciting period for ADVANZ PHARMA, our stakeholders, and all our employees across the globe,” said Graeme Duncan, chief executive officer. “This new corporate identity, and the accompanying rebranding that we are working on, will help define ADVANZ PHARMA as a global pharmaceutical company that is determined to help innovate, shape and grow the specialty, off-patent sector. We will aim to go beyond what we have achieved in the past, and current industry standards, as we look to capitalize on this new start.”

ADVANZ PHARMA represents a refocussed and redefined direction that will build on the Company’s current capabilities, and global footprint across more than 90 countries, so that it can meet the increasingly complex needs of global healthcare systems.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters